6BL-20625-68556
2 vaccinations
1 coded response
10 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 223 / VA
- Registered
- 2021-02-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-12
Registered in v-safe
-
2021-02-12
Dose 1 — Pfizer-BioNTech
- 2021-02-12
- 2021-02-14
-
2021-02-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness · Fatigue or tirednessAdult check-in
- 2021-02-26
-
2021-03-04
Dose 2 — Pfizer-BioNTech
-
2021-03-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea, VomitingAdult check-in
- 2021-03-06
- 2021-03-08
- 2021-03-27
-
2021-04-08
Survey response — day 35, dose 2MedDRA: Exposure during pregnancy — Feeling: GoodFree text: PregnantMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-12 | Pfizer-BioNTech | |
| 2 | 2021-03-04 | Pfizer-BioNTech |
Free text
Release 7 — day 35, dose 2
Symptoms: Pregnant
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Exposure during pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release